222 related articles for article (PubMed ID: 34462446)
21. Knockdown of circular RNA CEP128 suppresses proliferation and improves cytotoxic efficacy of temozolomide in glioma cells by regulating miR-145-5p.
Hua L; Huang L; Zhang X; Feng H; Shen B
Neuroreport; 2019 Dec; 30(18):1231-1238. PubMed ID: 31599823
[TBL] [Abstract][Full Text] [Related]
22. Circ_0005198 enhances temozolomide resistance of glioma cells through miR-198/TRIM14 axis.
Deng Y; Zhu H; Xiao L; Liu C; Meng X
Aging (Albany NY); 2020 Dec; 13(2):2198-2211. PubMed ID: 33316781
[TBL] [Abstract][Full Text] [Related]
23. AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation.
Tang Z; Yang G; Wang X; Chen F; Liao Z; Zhang Z; Liu Z; Zeng W; Fang M; Wang W; Sun X; Huo G
J Neurooncol; 2020 Sep; 149(2):231-242. PubMed ID: 32909117
[TBL] [Abstract][Full Text] [Related]
24. AS602801 sensitizes glioma cells to temozolomide and vincristine by blocking gap junction communication between glioma cells and astrocytes.
Zhang S; Gong Y; Wang H; Li Z; Huang Y; Fu X; Xiang P; Fan T
J Cell Mol Med; 2021 Apr; 25(8):4062-4072. PubMed ID: 33609076
[TBL] [Abstract][Full Text] [Related]
25. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981
[TBL] [Abstract][Full Text] [Related]
27. Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cells.
Hasan MN; Luo L; Ding D; Song S; Bhuiyan MIH; Liu R; Foley LM; Guan X; Kohanbash G; Hitchens TK; Castro MG; Zhang Z; Sun D
Theranostics; 2021; 11(3):1295-1309. PubMed ID: 33391535
[No Abstract] [Full Text] [Related]
28. miR-23b-5p promotes the chemosensitivity of temozolomide via negatively regulating TLR4 in glioma.
Gao K; Wang T; Qiao Y; Cui B
Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):979-987. PubMed ID: 34110366
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas.
Ulasov I; Thaci B; Sarvaiya P; Yi R; Guo D; Auffinger B; Pytel P; Zhang L; Kim CK; Borovjagin A; Dey M; Han Y; Baryshnikov AY; Lesniak MS
Cancer Med; 2013 Aug; 2(4):457-67. PubMed ID: 24156018
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.
Bao Z; Chen L; Guo S
J Cell Biochem; 2019 Jun; 120(6):10205-10214. PubMed ID: 30592329
[TBL] [Abstract][Full Text] [Related]
32. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
33. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/
Chen M; Cheng Y; Yuan Z; Wang F; Yang L; Zhao H
Cancer Biother Radiopharm; 2020 Mar; 35(2):101-108. PubMed ID: 31750728
[No Abstract] [Full Text] [Related]
34. Astrocyte elevated gene-1 interacts with Akt isoform 2 to control glioma growth, survival, and pathogenesis.
Hu B; Emdad L; Bacolod MD; Kegelman TP; Shen XN; Alzubi MA; Das SK; Sarkar D; Fisher PB
Cancer Res; 2014 Dec; 74(24):7321-32. PubMed ID: 25304263
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of hsa_circ_0000936 sensitizes resistant glioma cells to temozolomide by sponging miR-1294.
Hua L; Huang L; Zhang X; Feng H
J Biosci; 2020; 45():. PubMed ID: 32975228
[TBL] [Abstract][Full Text] [Related]
36. LINC00470 promotes tumour proliferation and invasion, and attenuates chemosensitivity through the LINC00470/miR-134/Myc/ABCC1 axis in glioma.
Wu C; Su J; Long W; Qin C; Wang X; Xiao K; Li Y; Xiao Q; Wang J; Pan Y; Liu Q
J Cell Mol Med; 2020 Oct; 24(20):12094-12106. PubMed ID: 32916774
[TBL] [Abstract][Full Text] [Related]
37. Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP
Ding Y; Zhou Y; Li Z; Zhang H; Yang Y; Qin H; Xu Q; Zhao L
Life Sci; 2020 Nov; 260():118411. PubMed ID: 32918978
[TBL] [Abstract][Full Text] [Related]
38. LINC01198 promotes proliferation and temozolomide resistance in a NEDD4-1-dependent manner, repressing PTEN expression in glioma.
Chen WL; Chen HJ; Hou GQ; Zhang XH; Ge JW
Aging (Albany NY); 2019 Aug; 11(16):6053-6068. PubMed ID: 31469661
[TBL] [Abstract][Full Text] [Related]
39. MiR-3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway.
Kong S; Cao Y; Li X; Li Z; Xin Y; Meng Y
J Cell Mol Med; 2020 Apr; 24(8):4677-4686. PubMed ID: 32181582
[TBL] [Abstract][Full Text] [Related]
40. Loss of ATRX suppresses ATM dependent DNA damage repair by modulating H3K9me3 to enhance temozolomide sensitivity in glioma.
Han B; Cai J; Gao W; Meng X; Gao F; Wu P; Duan C; Wang R; Dinislam M; Lin L; Kang C; Jiang C
Cancer Lett; 2018 Apr; 419():280-290. PubMed ID: 29378238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]